www.clinicalleader.com
Open in
urlscan Pro
20.185.12.70
Public Scan
Submitted URL: http://nl.clinicalleader.com/dc/6r9ayGBvBoEwsn5nbtZJ3md-NVLWlK2A9_yJW60spuo7MdvgF9h4TD1CxM9lLluzMq3AEQlwm6tKG4JO5z6Op1KzQmSvk...
Effective URL: https://www.clinicalleader.com/doc/weekly-newsletter-schedule-0001?vm_tId=2588552&vm_nId=84585&user=d0fcfd18-077c-4792-92e1-541...
Submission: On May 28 via api from US — Scanned from DE
Effective URL: https://www.clinicalleader.com/doc/weekly-newsletter-schedule-0001?vm_tId=2588552&vm_nId=84585&user=d0fcfd18-077c-4792-92e1-541...
Submission: On May 28 via api from US — Scanned from DE
Form analysis
1 forms found in the DOMGET /search
<form method="get" class="form-inline nav-search pr-0" action="/search">
<input class="form-control-sm" name="keyword" type="search" maxlength="250" placeholder="Search" aria-label="Search">
<button type="submit" class="btn-sm btn-dark">
<i class="fas fa-search fa-sm"></i>
</button>
</form>
Text Content
Get more clinical research insight with our FREE newsletter sign me up Log In or Subscribe Trial Design Partnering Clinical Technologies Regulatory Market Research Find A Partner CRO Services (Phase I-III) Clinical Trial Software and Services Consulting & Regulatory Partners Patient & Site Solutions Events Clinical Leader Live Clinical Leader Solutions Expo CLINICAL LEADER THEMED NEWSLETTERS: PERSONALIZE YOUR EXPERIENCE Since 2011, our Monday/Wednesday editorial newsletters have been an effective means of keeping biopharma professionals up to speed with the latest developments and innovations in the clinical research and development industry. These newsletters have always covered a broad range of trial-related topics, from study design to patient recruitment to data management, just to name a few. To help our readers accomplish their goals and solve their biggest challenges in clinical research, we wanted to develop and deliver more of the content they want and make it easier for them to find and access it. To personalize the reader experience, the Clinical Leader team solicited reader feedback to learn their theme preferences and topic needs. Based on that feedback, we decided to split our two expansive weekly newsletters into five slimmed-down, topic-specific daily newsletters. Here is the new schedule for these themed newsletters: Sign up today to start receiving newsletters on topics of interest to you. If you are already a Clinical Leader subscriber, you can update your topic preferences by visiting your profile page. WHAT ARE THE TOPIC PREFERENCES OF OTHER CLINICAL LEADER READERS? Check out the selections of a few hand-picked readers: Free Clinical Leader Newsletter YOU MAY ALSO LIKE... * 03.27.21 -- FOUR STEPS SPONSORS CAN TAKE TO INCREASE PATIENT RECRUITMENT 03/27/21 Clinical Leader Newsletter * SAREPTA THERAPEUTICS ANNOUNCES FDA CLEARANCE OF IND FOR THE COMPANY’S PPMO EXON 51 CANDIDATE, SRP-5051 Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare neuromuscular diseases,... * POINT OF CARE SOLUTIONS FOR PHARMACEUTICAL CLINICAL TRIALS Blinded Diagnostics is a contract service organization specializing in same day lab test results using point-of-care diagnostic platforms to optimize patient enrollment testing, blinded studies,... * FDA LIFTS HEAT BIOLOGICS PARTIAL CLINICAL HOLD Heat Biologics, Inc. (“Heat”) (Nasdaq:HTBX), an immuno-oncology company developing novel therapies that activate a patient’s immune system against cancer, announced that the U.S. * SOLID BIOSCIENCES ANNOUNCES CLINICAL HOLD ON SGT-001 PHASE I/II CLINICAL TRIAL FOR DUCHENNE MUSCULAR DYSTROPHY Solid Biosciences Inc. today announced it has received notification from the U.S. Food and Drug Administration (FDA) that IGNITE DMD, its Phase I/II clinical trial for SGT-001 microdystrophin gene... * LILLY/ENTOS DEAL REINFORCES THE SIGNIFICANCE OF DELIVERY MECHANISMS FOR NUCLEIC ACID-BASED THERAPIES * PUSHING BEYOND THE STATUS QUO IN TRIAL OVERSIGHT * TIGENIX ANNOUNCES SIX-MONTH PHASE I/II RESULTS OF ALLOCSC-01 IN ACUTE MYOCARDIAL INFARCTION * CLINICAL PRACTICE IS AHEAD OF CLINICAL TRIALS WITH TECHNOLOGY USE: EMR VS. EPRO * HEXOSKIN: CLOTHING THAT RECORDS MEDICAL DATA? * AN INTRODUCTION TO APPLICATIONS OF ADAPTIVE DESIGN * RESULTS FROM PHASE 2 EXPLORATORY CLINICAL STUDY SUPPORT CONTINUED DEVELOPMENT OF GANAXOLONE IN FRAGILE X SYNDROME This website uses cookies to ensure you get the best experience on our website. Learn more Got it! PARTNER WITH US * Request More Information * Our Partners SUBSCRIBE * Newsletter * Follow Us on LinkedIn LIFE SCIENCE CONNECT * Bioprocess Online * Biosimilar Development * Cell & Gene * Drug Discovery * Laboratory Network * Life Science Leader Magazine * Med Device Online * Outsourced Pharma * Pharmaceutical Online EDITORIAL * Archived Newsletters * Article Reprints * Editorial Submission Guidelines * Editorial Advisory Board * The Expert Network EVENTS * CMO Leadership Awards * CRO Leadership Awards LEARN MORE * About Us * Contact Us * Work For Us Copyright © 1996-2024 VertMarkets, Inc. All Rights Reserved. Terms of Use. Privacy Statement. Subscriber Request Form. Don't sell my information ×